AU7101391A - Method for the immunological determination of ligands - Google Patents

Method for the immunological determination of ligands

Info

Publication number
AU7101391A
AU7101391A AU71013/91A AU7101391A AU7101391A AU 7101391 A AU7101391 A AU 7101391A AU 71013/91 A AU71013/91 A AU 71013/91A AU 7101391 A AU7101391 A AU 7101391A AU 7101391 A AU7101391 A AU 7101391A
Authority
AU
Australia
Prior art keywords
binding
ligand
determined
immunological determination
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU71013/91A
Other versions
AU647449B2 (en
Inventor
Gerhard Bienhaus
Arno Deger
Roland Schenck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU7101391A publication Critical patent/AU7101391A/en
Application granted granted Critical
Publication of AU647449B2 publication Critical patent/AU647449B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Method for the immunological determination of a ligand, in which the ligand to be determined is reacted with a) at least 2 molecules of a substance P2 which is capable of specific binding, with at least one of these molecules carrying a label, and b) a receptor R which consists of a binding partner P1 which is capable of monovalent binding with P2, and of a binding site R1 for the ligand to be determined, and then the label is determined, and a reagent for the immunological determination of a ligand, which contains a substance P2 which is capable of specific binding and is at least partially in labelled form, and a receptor R which consists of a binding partner P1 which is capable of monovalent binding with P2 and of a binding site R1 for the ligand to be determined.
AU71013/91A 1990-02-26 1991-02-12 Method for the immunological determination of ligands Ceased AU647449B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4006054 1990-02-26
DE4006054A DE4006054A1 (en) 1990-02-26 1990-02-26 METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF LIGANDS

Publications (2)

Publication Number Publication Date
AU7101391A true AU7101391A (en) 1991-08-29
AU647449B2 AU647449B2 (en) 1994-03-24

Family

ID=6401009

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71013/91A Ceased AU647449B2 (en) 1990-02-26 1991-02-12 Method for the immunological determination of ligands

Country Status (9)

Country Link
EP (1) EP0444561B1 (en)
JP (1) JP2501960B2 (en)
KR (1) KR940008091B1 (en)
AT (1) ATE145479T1 (en)
AU (1) AU647449B2 (en)
CA (1) CA2034922A1 (en)
DE (2) DE4006054A1 (en)
ES (1) ES2096596T3 (en)
ZA (1) ZA911343B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138251B1 (en) 1996-04-22 2006-11-21 Amgen Inc. Polynucleotides encoding a neurotrophic factor receptor
JP2002505576A (en) * 1997-05-30 2002-02-19 アムジエン・インコーポレーテツド Neurotrophic factor receptor
CA2547351A1 (en) 2003-12-01 2005-07-07 Dade Behring Marburg Gmbh Homogeneous detection method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4495296A (en) * 1979-05-21 1985-01-22 New York Blood Center, Inc. Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays
IL75020A (en) * 1984-05-10 1988-10-31 Abbott Lab Biotin-antibiotin immunoassay for the detection of ligands
JPS60252265A (en) * 1984-05-29 1985-12-12 Toray Ind Inc Light emitting reagent and method for measuring biologically active material using said reagent
IE64286B1 (en) * 1988-05-25 1995-07-26 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable vessel therefor
DE3834766A1 (en) * 1988-10-12 1990-04-26 Boehringer Mannheim Gmbh METHOD FOR DETERMINING A SPECIFICALLY BINDABLE SUBSTANCE

Also Published As

Publication number Publication date
ZA911343B (en) 1991-11-27
EP0444561B1 (en) 1996-11-20
DE4006054A1 (en) 1991-08-29
JP2501960B2 (en) 1996-05-29
AU647449B2 (en) 1994-03-24
EP0444561A2 (en) 1991-09-04
KR940008091B1 (en) 1994-09-02
ATE145479T1 (en) 1996-12-15
CA2034922A1 (en) 1991-08-27
DE59108355D1 (en) 1997-01-02
ES2096596T3 (en) 1997-03-16
EP0444561A3 (en) 1992-10-14
JPH04216465A (en) 1992-08-06
KR910021586A (en) 1991-12-20

Similar Documents

Publication Publication Date Title
AU3090889A (en) Method for determination of a polyvalent substance using an immunoaggregate
AU2543777A (en) Specific binding assay method'and reagent means
CA2099433A1 (en) Enhancement of signal in immunoassays using microparticles which contain different detectable substances
CA2177362A1 (en) Sensor device for sandwich assay
EP0710293A4 (en) Lyophilized ligand-receptor complexes for assays and sensors
EP0407904A3 (en) Method for the determination of an analyte
DE59409947D1 (en) Reduction of the hook effect in immunoassays with particulate carrier material
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
AU2603288A (en) Bidentate conjugate and method of use thereof
ATE67599T1 (en) HETEROGENOUS IMMUNOASSAY.
AU647449B2 (en) Method for the immunological determination of ligands
AU3996693A (en) Process for the immunochemical determination of an analyte
ES8605106A1 (en) Process and reagent for the quantitative determination of free thyroxine in plasma, serum and full blood.
GR3009564T3 (en)
CA2004642A1 (en) Process for the detection of compounds containing carbohydrate and a suitable reagent therefor
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
ATE77487T1 (en) IMMUNOLOGICAL DETERMINATION METHOD FOR THE DETERMINATION OF FREE SUBSTANCES HAVING HAD PROPERTIES.
AU1718588A (en) Method for the determination of albumin in biological fluids
DE3172795D1 (en) Process for the determination of ligands, test kit for carrying out the process and its application
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
EP0650054A3 (en) Process and device for obtaining and detecting immunologically reactive substances from the gas phase.
JPS5386014A (en) Quantitative analysis of antigen and antibody
HUT61619A (en) Method for radioimmunological derminic 5-hydroxi- 6,8,11,14-eicosatetraen- acid content of the biological samples
DE59708051D1 (en) Stabilization of standard solutions using conjugates